Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome

Journal of Clinical Oncology

Volumn 16, Issue 7, 1998, Pages 2478-2485

  Scheurlen, Wolfram G ^a   Schwabe, Georg C ^b   Joos, Stefan ^b   Mollenhauer, Jan ^b   Sörensen, Niels ^b   Kühl, Joachim ^b  

^a Children's Hospital   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADOLESCENT; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DNA DETERMINATION; FEMALE; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; INFANT; MALE; NEUROECTODERM TUMOR; ONCOGENE C MYC; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SOUTHERN BLOTTING;

EID: 0031803734     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.7.2478     Document Type: Article

References (42)

1. Duffner P, Horowitz M, Krischer J, et al: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328:1725-1731, 1993
2. Dunkel I, Finlay J: High dose chemotherapy with autologous stem cell rescue for patients with medulloblastoma. J Neurooncol 29:69-74, 1996
3. Mahoney D, Stromer D, Camilla B, et al: High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: A pilot Pediatric Oncology Group study. J Clin Oncol 14:382-388, 1996
4. Trojanowski J, Tohyama T, Lee V: Medulloblastomas and related primitive neuroectodermal brain tumors of childhood recapitulate molecular milestones in the maturation of neuroblasts. Mol Chem Neuropathol 17:121-135, 1992
5. Kozmik Z, Sure U, Ruedi D, et al: Deregulated expression of PAX5 in medulloblastoma. Proc Natl Acad Sci USA 92:5709-5713, 1995
6. Raffel C, Gilles F, Weinberg K: Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood. Cancer Res 50:587-591, 1990
7. Thomas G, Raffel C: Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors. Cancer Res 51:639-643, 1991
8. Fults D, Petronio J, Noblett B, et al: Chromosome 11p15 deletions in human malignant astrocytomas and primitive neuroectodermal tumors. Genomics 14:799-801, 1992
9. Cogen P, Daneshvar L, Metzger A, et al: Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am J Hum Genet 50:584-589, 1992
10. Biegel J, Burk C, Barr F, et al: Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res 52:3391-3395, 1992
11. Neumann E, Kalousek D, Norman M, et al: Cytogenetic analysis of 109 pediatric central nervous system tumors. Cancer Genet. Cytogenet 71:40-49, 1993
12. Fujii Y, Hongo T, Hayashi Y: Chromosome analysis of brain tumors in childhood. Genes Chromosom Cancer 11:205-215, 1994
13. Albrecht S, von Deimling A, Pietsch T, et al: Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11p and 17p in medulloblastomas. Neuropathol Appl Neurobiol 20:74-81, 1994
14. Schütz B, Scheurlen W, Krauss J, et al: Mapping of chromosomal gains and losses in primitive neuroectodermal tumors by comparative genomic hybridization. Genes Chromosom Cancer 16:196-203, 1996
15. Kühl J, Bamberg M, Berthold F, et al: Medulloblastoma -Prognostic factors. Results of the german multicenter pilot trial HIT '88/89 investigating preradiation chemotherapy. Med Pediatr Oncol 21:564, 1993 (abstr)
16. Kühl J, Berthold F, Bode U, et al: Preradiation chemotherapy of children with poor-prognosis medulloblastoma: Response rate and toxicity of the ifosfamide-containing multidrug regimen HIT '88/'89. Am J Pediatr Hematol Oncol 15:567-571, 1993 (suppl A)
17. Kühl J, Mittler U, Urban C, et al: Neoadjuvant chemotherapy of medulloblastoma - Recent results of the HIT-trials. J Neurooncol 30:128, 1996 (abstr)
18. Bailey C, Gnekow A, Wellek S, et al: Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 25:166-178, 1995
19. Miller S, Dykes D, Polesky H: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988
20. Scheurlen W, Seranski P, Mincheva A, et al: High resolution deletion mapping of chromosome 17p in childhood primitive neuroectodermal tumors (PNET) reveals a common chromosomal disruption within the Smith-Magenis region, an unstable region in band 17p11.2. Genes Chromosom Cancer 18:50-58, 1997
21. Nishimura D, Murray J: A tetranucleotide repeat for the F13B locus. Nucleic Acids Res 20:1167, 1992
22. Hahn H, Wicking C, Zaphiropoulos P, et al: Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85:841-851, 1996
23. Johnson R, Rothman A, Xie J, et al: Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272:1668-1671, 1996
24. Mollenhauer J, Wiemann S, Scheurlen W, et al: DMBT1, a new member of the SRCR superfamily, is located at chromosome 10q23.3-q26.1 and deleted in malignant brain tumors. Nat Genet 17:32-39, 1997
25. Bentz M, Schröder M, Herz M, et al: Detection of trisomy 8 on blood smears using fluorescence in situ hybridization. Leukemia 7:752-757, 1993
26. Wilgenbus K, Coy J, Mincheva A, et al: Ordering of 66 markers along human chromosome 17p and chromosomal assignment of novel transcript homologues to FMR1. Cytogenet Cell Genet 73:240-243, 1996
27. Joos S, Falk M, Lichter P, et al: Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb. Hum Mol Genet 1:625-632, 1992
28. Wilgenbus K, Mincheva A, Korn B, et al: IRS-longe range PCR: A simple method for amplification of human genomic DNA from complex sources. Meth Mol Cell Biol 5:214-221, 1995
29. Lichter P, Tang C, Call K, et al: High resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 247:64-69, 1990
30. Boyle A, Feltquite C, Dracopoli N, et al: Rapid physical mapping of cloned DNA on mouse chromosomes by fluorescence in situ hybridization. Genomics 12:106-112, 1992
31. Kalbfleisch J, Prentice R: The Statistical Analysis of Failure of Time Data. New York, NY, Wiley, 1989
32. Bigner S, Vogelstein B: Cytogenetics and molecular genetics of malignant gliomas and medulloblastoma. Brain Pathol 1:12-18, 1990
33. Kraus J, Koch A, Silbrecht S, et al: Loss of heterozygosity at locus F13B on chromosome 1q in human medulloblastoma. Int J Cancer 67:11-15, 1996
34. Blaeker H, Rasheed A, McLendon R, et al: Microsatellite analysis of childhood brain tumors. Genes Chromosom Cancer 15:54-63, 1996
35. Bigner S, Friedman H, Vogelstein B, et al: Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Res 50:2347-2350, 1990
36. Secal R, Gounmerova L, Kwon Y, et al: Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA 91:12867-12871, 1994
37. Batra S, McLendon R, Seok Koo J, et al: Prognostic implications of chromosome 17p deletions in human medulloblastomas. J Neurooncol 24:39-45, 1995
38. Emadian S, McDonald J, Gerken S, et al: Correlation of chromosome 17p loss with clinical outcome in medulloblastoma. Clin Cancer Res 2:1559-1564, 1996
39. Badiali M, Pession A, Basso G, et al: N-myc and c-myc oncogenes amplifications in medulloblastomas. Evidence of particularly aggressive behaviour of a tumor with c-myc amplification. Tumori 77:118-121, 1991
40. Laurent J, Chang C, Cohen M: A classification system for primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa. Cancer 56:1807-1809, 1985
41. Duffner P, Cohen M, Myers M, et al: Survival of children with brain tumors: SEER program, 1973-1980. Neurology 36:597-601, 1986
42. Cogen P: Prognostic significance of molecular genetic markers in childhood brain tumors. Pediatr Neurosurg 17:245-250, 1991-1992